Eclinicalmedicine SCIE

國際簡稱：Eclinicalmedicine 參考譯名：臨床醫(yī)學(xué)

主要研究方向：Medicine-Medicine (all) 非預(yù)警期刊審稿周期： 10 Weeks

《臨床醫(yī)學(xué)》(Eclinicalmedicine)是一本由Elsevier出版的以Medicine-Medicine (all)為研究特色的國際期刊，發(fā)表該領(lǐng)域相關(guān)的原創(chuàng)研究文章、評論文章和綜述文章，及時報道該領(lǐng)域相關(guān)理論、實踐和應(yīng)用學(xué)科的最新發(fā)現(xiàn)，旨在促進(jìn)該學(xué)科領(lǐng)域科學(xué)信息的快速交流。該期刊是一本開放期刊，近三年沒有被列入預(yù)警名單。該期刊享有很高的科學(xué)聲譽，影響因子不斷增加，發(fā)行量也同樣高。

1區(qū) 中科院分區(qū)
Q1 JCR分區(qū)
511 年發(fā)文量
9.6 IF影響因子
開放是否OA
English 出版語言

eClinicalMedicine covers clinical research from all medical specialties—from diagnosis to treatment, prevention to palliative care, and health promotion to health policy and equity. We aim to help frontline health professionals navigate the complex and rapid health transitions facing societies worldwide and aspire to be a catalyst to rethink and reframe the future of health and health care with the ultimate goal of strengthening health systems as core institutions.As a popular journal among medical professionals worldwide, it helps them improve the quality and efficiency of healthcare services by providing the latest medical research findings and clinical practice guidelines.

[ 查看全部 ]

投稿咨詢加急咨詢

Eclinicalmedicine期刊信息

ISSN：2589-5370
出版語言：English
是否OA：開放
E-ISSN：2589-5370
出版地區(qū)：United Kingdom
是否預(yù)警：否
出版商：Elsevier
開源占比：0.8965
Gold OA文章占比：78.40%
OA被引用占比：
出版國人文章占比：0
出版撤稿占比：
研究類文章占比：82.19%

Eclinicalmedicine CiteScore評價數(shù)據(jù)（2024年最新版）

CiteScore

SJR

SNIP

CiteScore 指數(shù)

18.9

3.522

2.507

學(xué)科類別	分區(qū)	排名	百分位
大類：Medicine 小類：General Medicine	Q1	16 / 636	97%

名詞解釋：CiteScore 是衡量期刊所發(fā)表文獻(xiàn)的平均受引用次數(shù)，是在 Scopus 中衡量期刊影響力的另一個指標(biāo)。當(dāng)年CiteScore 的計算依據(jù)是期刊最近4年（含計算年度）的被引次數(shù)除以該期刊近四年發(fā)表的文獻(xiàn)數(shù)。例如，2022年的 CiteScore 計算方法為：2022年的 CiteScore =2019-2022年收到的對2019-2022年發(fā)表的文件的引用數(shù)量÷2019-2022年發(fā)布的文獻(xiàn)數(shù)量注：文獻(xiàn)類型包括：文章、評論、會議論文、書籍章節(jié)和數(shù)據(jù)論文。

Eclinicalmedicine中科院評價數(shù)據(jù)

中科院 2023年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	1區(qū)	MEDICINE, GENERAL & INTERNAL 醫(yī)學(xué)：內(nèi)科	1區(qū)

中科院 2022年12月升級版

Top期刊	綜述期刊	大類學(xué)科		小類學(xué)科
是	否	醫(yī)學(xué)	1區(qū)	MEDICINE, GENERAL & INTERNAL 醫(yī)學(xué)：內(nèi)科	1區(qū)

Eclinicalmedicine JCR評價數(shù)據(jù)（2023-2024年最新版）

按JIF指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：MEDICINE, GENERAL & INTERNAL	SCIE	Q1	12 / 325	96.5%

按JCI指標(biāo)學(xué)科分區(qū)	收錄子集	分區(qū)	排名	百分位
學(xué)科：MEDICINE, GENERAL & INTERNAL	SCIE	Q1	11 / 329	96.81%

Eclinicalmedicine歷年數(shù)據(jù)統(tǒng)計

影響因子

中科院分區(qū)

Eclinicalmedicine中國學(xué)者發(fā)文選摘

1、CT-based radiomics signature of visceral adipose tissue for prediction of disease progression in patients with Crohn?s disease: a multicentre cohort study
Author: Li, Xuehua; Zhang, Naiwen; Hu, Cicong; Lin, Yuqin; Li, Jiaqiang; Li, Zhoulei; Cui, Enming; Shi, Li; Zhuang, Xiaozhao; Li, Jianpeng; Lu, Jiahang; Wang, Yangdi; Liu, Renyi; Yuan, Chenglang; Lin, Haiwei; He, Jinshen; Ke, Dongping; Tang, Shanshan; Zou, Yujian; He, Bo; Sun, Canhui; Chen, Minhu; Huang, Bingsheng; Mao, Ren; Feng, Shi-Ting

Journal: ECLINICALMEDICINE. 2023; Vol. 56, Issue , pp. -. DOI: 10.1016/j.eclinm.2022.101805
2、Effect of stereotactic body radiotherapy dose escalation plus pembrolizumab and trametinib versus stereotactic body radiotherapy dose escalation plus gemcitabine for locally recurrent pancreatic cancer after surgical resection on survival outcomes: A secondary analysis of an open-label, randomised, controlled, phase 2 trial
Author: Zhu, Xiaofei; Liu, Wenyu; Cao, Yangsen; Ju, Xiaoping; Zhao, Xianzhi; Jiang, Lingong; Ye, Yusheng; Zhang, Huojun

Journal: ECLINICALMEDICINE. 2023; Vol. 55, Issue , pp. -. DOI: 10.1016/j.eclinm.2022.101764
3、Clinical outcomes following discontinuation of renin-angiotensin-system inhibitors in patients with type 2 diabetes and advanced chronic kidney disease: A prospective cohort study
Author: Yang, Aimin; Shi, Mai; Lau, Eric S. H.; Wu, Hongjiang; Zhang, Xinge; Fan, Baoqi; Kong, Alice P. S.; Luk, Andrea O. Y.; Ma, Ronald C. W.; Chan, Juliana C. N.; Chow, Elaine

Journal: ECLINICALMEDICINE. 2023; Vol. 55, Issue , pp. -. DOI: 10.1016/j.eclinm.2022.101751
4、Use of non-selective B-blockers is safe in hospitalised decompensated cirrhosis patients and exerts a potential anti-inflammatory effect: Data from the ATTIRE trial
Author: Tittanegro, Thais; China, Louise; Forrest, Ewan; Kallis, Yiannis; Ryder, Stephen D.; Wright, Gavin; Freemantle, Nick; O'Brien, Alastair

Journal: ECLINICALMEDICINE. 2023; Vol. 55, Issue , pp. -. DOI: 10.1016/j.eclinm.2022.101716
5、Dementia risk after major elective surgery based on the route of anaesthesia: A propensity score-matched population-based cohort study
Author: Sun, Mingyang; Chen, Wan-Ming; Wu, Szu-Yuan; Zhang, Jiaqiang

Journal: ECLINICALMEDICINE. 2023; Vol. 55, Issue , pp. -. DOI: 10.1016/j.eclinm.2022.101727
6、Genotype-guided model significantly improves accuracy of tacrolimus initial dosing after liver transplantation
Author: Shi, Baojie; Liu, Yuan; Liu, Dehua; Yuan, Liyun; Guo, Wenzhi; Wen, Peihao; Su, Zhaojie; Wang, Jie; Xu, Shiquan; Xia, Junjie; An, Wenbin; Wang, Rui; Wen, Peizhen; Xing, Tonghai; Zhang, Jinyan; Gu, Haitao; Wang, Zhaowen; Zhong, Lin; Fan, Junwei; Li, Hao; Zhang, Weituo; Peng, Zhihai

Journal: ECLINICALMEDICINE. 2023; Vol. 55, Issue , pp. -. DOI: 10.1016/j.eclinm.2022.101752
7、Early detection and prognosis prediction for colorectal cancer by circulating tumour DNA methylation haplotypes: A multicentre cohort study
Author: Mo, Shaobo; Dai, Weixing; Wang, Hui; Lan, Xiaoliang; Ma, Chengcheng; Su, Zhixi; Xiang, Wenqiang; Han, Lingyu; Luo, Wenqin; Zhang, Long; Wang, Renjie; Zhang, Yaodong; Zhang, Wenming; Yang, Lin; Lu, Renquan; Guo, Lin; Zheng, Ying; Huang, Mingzhu; Xu, Ye; Liang, Li; Cai, Sanjun; Cai, Guoxiang

Journal: ECLINICALMEDICINE. 2023; Vol. 55, Issue , pp. -. DOI: 10.1016/j.eclinm.2022.101717
8、Mental health outcomes in parents of children with a cancer diagnosis in Sweden: A nationwide cohort study
Author: Liu, Yishan; Sundquist, Jan; Sundquist, Kristina; Zheng, Deqiang; Ji, Jianguang

Journal: ECLINICALMEDICINE. 2023; Vol. 55, Issue , pp. -. DOI: 10.1016/j.eclinm.2022.101734